Cargando…
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice
Fenofibrate (FBR), an oral medication used to treat dyslipidemia, is a ligand of the peroxisome proliferator-activated receptor α (PPARα), a nuclear receptor that regulates the expression of metabolic genes able to control lipid metabolism and food intake. PPARα natural ligands include fatty acids (...
Autores principales: | Murru, Elisabetta, Muntoni, Anna Lisa, Manca, Claudia, Aroni, Sonia, Pistis, Marco, Banni, Sebastiano, Carta, Gianfranca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821630/ https://www.ncbi.nlm.nih.gov/pubmed/36614161 http://dx.doi.org/10.3390/ijms24010709 |
Ejemplares similares
-
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation
por: Murru, Elisabetta, et al.
Publicado: (2021) -
PPAR-Alpha Agonists as Novel Antiepileptic Drugs: Preclinical Findings
por: Puligheddu, Monica, et al.
Publicado: (2013) -
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles
por: Murru, Elisabetta, et al.
Publicado: (2022) -
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia
por: De Felice, Marta, et al.
Publicado: (2018) -
Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-α Activation in Obese Subjects Post Bariatric Surgery
por: Manca, Claudia, et al.
Publicado: (2021)